

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance ...
HMGCLL1 is a Predictive Biomarker for Deep Molecular Response to Imatinib Therapy in Chronic Myeloid
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance ...
HMGCLL1 is a Predictive Biomarker for Deep Molecular Response to Imatinib Therapy in Chronic Myeloid